Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
Clinical trial NCT02747927 · COMPLETED
Trial details
- NCT number
- NCT02747927
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-26
- Primary completion
- 2018-07-11
- Enrollment
- 20099
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.